Has Keith Reinhardt, MD received payments from drug or device companies?

Yes. Drug and device makers reported $128,994 in general payments to Keith Reinhardt, MD across 206 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Keith Reinhardt, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Keith Reinhardt, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Keith Reinhardt, MD

Orthopaedic Surgery · Bay Shore, NYNPI 1427224591

Payments from drug & device makers

$128,994in general payments, 2019–2025

Across 206 payments — averaging $626.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Stryker$123K
Medical Device Business Services, Inc.$2K
Globus Medical$2K
Zimmer Biomet$887
Smith+Nephew$281
UOC USA Inc$84
plus $74 from 1 others

What the payments were for

Consulting fees$110,61486%
Travel & lodging$12,1839%
Food & beverage$6,1965%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Stryker	181	$123,463
Medical Device Business Services, Inc.	2	$2,365
Globus Medical	6	$1,840
Zimmer Biomet	13	$887
Smith+Nephew	2	$281
UOC USA Inc	1	$84
Johnson & Johnson	1	$74

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$128,994 in reported general payments places this provider in the 85th percentile of 1,079 orthopaedic surgery providers in New York.

See all orthopaedic surgery providers in New York →

Medicare billing

Part B allowed, 2024

$808,574

Medicare patients

923

Services billed

33,843

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Meloxicam	24	$32

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Bay Shore

Anthony RomeoNew York$27M
Lawrence LenkeNew York$26.8M
Edwin SuNew York$14.1M
William RicciNew York$11.6M
Steven HaasNew York$11.5M
Giles ScuderiNew York$10.9M
Joseph ZuckermanNew York$9.9M
Evan FlatowNew York$9.6M
Bradford ParsonsNew York$9.4M
Geoffrey WestrichNew York$8M

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →